Results 121 to 130 of about 9,306,982 (363)

Cerebral Glucose Metabolism in Parkinson’s Disease [PDF]

open access: bronze, 1984
W. R. Wayne Martin   +8 more
openalex   +1 more source

Additional file 2 of Altered gut microbiota and inflammatory cytokine responses in patients with Parkinsonâ s disease

open access: yes, 2019
: Table S1 Clinical characteristics of the study participants. Table S2 General linear models for fecal genera based on differences between patients with PD and healthy controls. (DOCX 19Â kb)
Chin-Hsien Lin   +10 more
openaire   +1 more source

Magnetic‐Driven Torque‐Induced Electrical Stimulation for Millisecond‐Scale Wireless Neuromodulation

open access: yesAdvanced Healthcare Materials, EarlyView.
MagTIES is a wireless neuromodulation technique with millisecond precision. It employs magnetic‐driven torque from magnetite nanodiscs to activate piezoelectric nanoparticles, enabling precise temporal control of neuronal activity and brain oscillations using weak, low‐frequency magnetic fields.
Chao‐Chun Cheng   +5 more
wiley   +1 more source

Angiotensin type 1 receptor activation promotes neuronal and glial alpha-synuclein aggregation and transmission

open access: yesnpj Parkinson's Disease
The brain renin-angiotensin system (RAS) has been related to dopaminergic degeneration, and high expression of the angiotensin II (AngII) type 1 receptor (AT1) gene is a marker of the most vulnerable neurons in humans.
Lucia Lage   +4 more
doaj   +1 more source

Knowledge mapping of ferroptosis in Parkinson’s disease: a bibliometric analysis: 2012–2023

open access: yesFrontiers in Aging Neuroscience
BackgroundFerroptosis is a crucial pathogenic mechanism in Parkinson’s disease, offering significant potential for pharmacological intervention. Despite its importance, the number of bibliometric analyses examining the relationship between ferroptosis ...
Juanqin Li   +7 more
doaj   +1 more source

Additional file 1: of Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinsonâ s disease

open access: yes, 2016
Supplementary Materials and Methods. (PDF 401Â kb)
Majbour, Nour   +13 more
openaire   +1 more source

Multifunctional Biomedical Devices with Closed‐Loop Systems for Precision Therapy

open access: yesAdvanced Healthcare Materials, EarlyView.
This review explores two major types of closed‐loop therapeutic systems: self‐sustained and externally triggered. It highlights recent advances in stimuli‐responsive materials, integrated bioelectronics, and data‐driven control strategies, offering insight into emerging strategies for personalized, responsive drug delivery.
Yixuan Leng, Rujie Sun
wiley   +1 more source

Bromocriptine in the Management of End of Dose Deterioration in Parkinson’s Disease [PDF]

open access: bronze, 1984
J. David Grimes   +5 more
openalex   +1 more source

Advances in Photonic Materials and Integrated Devices for Smart and Digital Healthcare: Bridging the Gap Between Materials and Systems

open access: yesAdvanced Materials, EarlyView.
This article summarizes significant technological advancements in materials, photonic devices, and bio‐interfaced systems, which demonstrate successful applications for impacting human healthcare via improved therapies, advanced diagnostics, and on‐skin health monitoring.
Seunghyeb Ban   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy